Video from AACC: Enzo BioChem CEO on COVID-19 test landscape

By Leo O'Connor, Editor in Chief
August 1, 2022

Enzo BioChem develops diagnostic tests and provides testing in centers throughout New York and its surrounding areas. CEO Hamid Erfanian spoke to us at AACC 2022 about the changes he sees in the in vitro diagnostics (IVD) landscape as the COVID-19 pandemic evolves.

Enzo BioChem develops diagnostic tests and provides testing in centers throughout New York and its surrounding areas. CEO Hamid Erfanian spoke to us at AACC 2022 about the changes he sees in the IVD landscape as the COVID-19 pandemic evolves.

Click on the video below for the interview.

Hamid Erfanian AACC interview

Enzo BioChem CEO Hamid Erfanian.

If you like this content, please share it with a colleague!

Related Reading

Video from AACC: Beckman Coulter partners with Scopio
Danaher’s Beckman Coulter Diagnostics has announced it has partnered with Scopio Labs to accelerate adoption of Scopio's next-generation peripheral blood...

Video from AACC: AACC president on Theranos, VALID Act
Dr. Stephen Master, president of the American Association for Clinical Chemistry, provided his thoughts about the main highlights of the 2022 AACC Annual...

Video from AACC: Cytovale immune-response test for sepsis
Cytovale CEO Ajay Shah discusses unmet needs in the sepsis testing market and the firm’s 10-minute direct-from-blood IntelliSep test.

Seegene outlines expansion strategies at AACC 2022
Seegene provided a glimpse of its global expansion initiatives at the 2022 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting...

Video from AACC: Highlights of Day 3
Highlights from the LabPulse.com (sister site of ScienceBoard.net) team for Day 3 of the American Association for Clinical Chemistry...